MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

This clinical trial studies magnetic resonance imaging (MRI) and gene expression in
diagnosing patients with abnormal cells in the breast duct that have not spread outside the
duct. MRI uses radio waves and a powerful magnet linked to a computer to create detailed
pictures of areas inside the body. MRI may help find and diagnose patients with breast
cancer. It may also help doctors predict a patient's response to treatment and help plan the
best treatment. Genetic studies may help doctors predict the outcome of treatment and the
risk for disease recurrence. Performing MRI with genetic studies may help determine the best
treatment for patients with breast cancer in situ.

Intervention

Magnetic Resonance Imaging, Therapeutic Conventional Surgery, Therapeutic Surgical Procedure, Radiation Therapy, Endocrine Therapy, Quality-of-Life Assessment, Laboratory Biomarker Analysis, Cytology Specimen Collection Procedure

Condition

Ductal Breast Carcinoma In Situ

Investigators

Constance Lehman

See list of participating sites